From innovation
‍to execution.

Marek Bartula is a Strategic Innovation Leader who started his adventure at Philips in video processing, analysis, and computer vision. Before co‑pioneering camera‑based monitoring of vital signs, including Philips’ first MRI‑embedded vital signs camera. He led the measurement of respiration from research through development, implementation, and on‑site clinical testing and validation, primarily at Mayo Clinic.

Marek later moved from the Netherlands to the US to manage broader innovation programs with major clinical partners and help bring disruptive monitoring technologies from concept to deployment.

Bringing a medical device from concept to market is rarely a straight path. Projects often stall, not because of a single major issue, but due to the accumulation of uncertainties such as shifting requirements, technical complexity, resource constraints, and regulatory challenges.

This presentation explores practical strategies for MedTech startups and scaleups to de-risk medical device development, helping them minimize delays, control costs, and avoid compliance setbacks.

Lamborghini Sotelo is an AI consultant at Corscience, improving AI enablement for medical device companies.

His background spans physics and photonics, doctoral research in biomaterials and laser physics, and project management, which allows him to coordinate effectively across engineering, regulatory, and business teams.

Maeva Schaller is Head of Operations Europe at Pilotfish, where she helps innovators bridge the gap between product development and industrialization.

With extensive experience in scaling complex hardware products from early prototypes to production, she has guided start-ups and established companies through the critical transition from concept to manufacturing.

In this session, Maeva will share practical lessons on preparing products, processes, and teams for the first production runs, helping attendees avoid common scaling pitfalls and move from a single prototype to the first production batches and beyond.

VP of Research and Development, Peter oversees system design disciplines for implantable and interventional cardiac devices, including usability, cybersecurity, verification and validation, and regulatory affairs.

With a background in chemistry and decades of experience in medical device quality and regulation, he has been responsible for one of the first class III quality management systems certified under the EU Medical Device Regulation (MDR) and has led global initiatives in risk management, post‑market surveillance, and recalls.